ACAD
34.36
+0.04
+0.12%
AEMD
5.56
+0.11
+2.02%
APRI
0.362
-0.021
-5.4308%
ARNA
1.68
0.00
0.00%
ATEC
0.31
-0.03
-8.82%
CNAT
1.93
0.00
0.00%
CRXM
0.171
0.00
0.00%
CYTX
2.19
0.00
0.00%
DXCM
92.09
+1.53
+1.69%
GNMK
8.8
+0.13
+1.50%
HALO
10.1
-0.2
-1.94%
ILMN
172.79
-0.96
-0.55%
INNV
0.45
-0.01
-2.17%
INO
9.14
+0.08
+0.88%
ISCO
2
+0.03
+1.52%
ISIS
57.56
0.00
0.00%
LGND
108.07
+1.25
+1.17%
LPTN
2.68
-0.5
-15.72%
MBVX
5.35
+0.24
+4.70%
MEIP
2.05
+0.01
+0.49%
MNOV
6.55
+0.08
+1.24%
MRTX
5.46
+0.04
+0.74%
MSTX
0.415
+0.001
+0.266%
NBIX
51.5
-0.03
-0.05%
NUVA
64.1
+0.59
+0.93%
ONCS
1.797
-0.033
-1.8087%
ONVO
4.01
-0.04
-0.99%
OREX
4.34
-0.07
-1.59%
OTIC
17.26
-0.05
-0.29%
QDEL
21.55
+0.24
+1.13%
RCPT
231.96
0.00
0.00%
RGLS
3.44
-0.03
-0.86%
RMD
67.32
-2.46
-3.53%
SPHS
3.89
-1.93
-33.16%
SRNE
6.96
+0.01
+0.14%
TROV
5.21
-0.2
-3.70%
VICL
4.1
-0.06
-1.44%
VOLC
18
0.00
0.00%
ZGNX
9.56
-0.04
-0.42%
ACAD
34.36
+0.04
+0.12%
AEMD
5.56
+0.11
+2.02%
APRI
0.362
-0.021
-5.4308%
ARNA
1.68
0.00
0.00%
ATEC
0.31
-0.03
-8.82%
CNAT
1.93
0.00
0.00%
CRXM
0.171
0.00
0.00%
CYTX
2.19
0.00
0.00%
DXCM
92.09
+1.53
+1.69%
GNMK
8.8
+0.13
+1.50%
HALO
10.1
-0.2
-1.94%
ILMN
172.79
-0.96
-0.55%
INNV
0.45
-0.01
-2.17%
INO
9.14
+0.08
+0.88%
ISCO
2
+0.03
+1.52%
ISIS
57.56
0.00
0.00%
LGND
108.07
+1.25
+1.17%
LPTN
2.68
-0.5
-15.72%
MBVX
5.35
+0.24
+4.70%
MEIP
2.05
+0.01
+0.49%
MNOV
6.55
+0.08
+1.24%
MRTX
5.46
+0.04
+0.74%
MSTX
0.415
+0.001
+0.266%
NBIX
51.5
-0.03
-0.05%
NUVA
64.1
+0.59
+0.93%
ONCS
1.797
-0.033
-1.8087%
ONVO
4.01
-0.04
-0.99%
OREX
4.34
-0.07
-1.59%
OTIC
17.26
-0.05
-0.29%
QDEL
21.55
+0.24
+1.13%
RCPT
231.96
0.00
0.00%
RGLS
3.44
-0.03
-0.86%
RMD
67.32
-2.46
-3.53%
SPHS
3.89
-1.93
-33.16%
SRNE
6.96
+0.01
+0.14%
TROV
5.21
-0.2
-3.70%
VICL
4.1
-0.06
-1.44%
VOLC
18
0.00
0.00%
ZGNX
9.56
-0.04
-0.42%
Home » Events

Biocom: Legislative Roundtable

Submitted by on October 6, 2008 – 7:54 pm

Biocom Legislative Roundtable with Senator Christine Kehoe, Wednesday, October 8, 2008 12:00 p.m. – 1:00 p.m., Biocom Boardroom

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Please prove you\'re human, solve this: *
Time limit is exhausted. Please reload CAPTCHA.